Company Filing History:
Years Active: 2006-2008
Title: The Innovative Contributions of Adam Jan Sanderson
Introduction
Adam Jan Sanderson is a notable inventor based in Basingstoke, GB. He has made significant contributions to the field of pharmacology through his innovative patents. With a total of two patents to his name, Sanderson's work focuses on the modulation of acetylcholine receptors, which play a crucial role in neurotransmission.
Latest Patents
Sanderson's latest patents include "Aza-cyclic compounds as modulators of acetylcholine receptors" and "Modulators of acetylcholine receptors." The first patent discloses compounds that comprise an aza-cyclic portion and an aromatic portion linked via a sulphur atom. These compounds are selective modulators of the beta 4 subtype nicotinic acetylcholine receptors and are useful for treating dysfunctions of the central and autonomic nervous systems. The second patent relates to thio-bridged aryl compounds that promote the release of neurotransmitters such as acetylcholine, dopamine, and norepinephrine. These compounds are also aimed at treating dysfunctions of the central and autonomic nervous systems.
Career Highlights
Throughout his career, Sanderson has worked with prominent companies, including Merck & Company, Inc. and Merck & Co., Inc. His experience in these organizations has contributed to his expertise in the field of pharmacology and drug development.
Collaborations
Some of Sanderson's notable coworkers include Peter Charles Astles and Stephen Richard Baker. Their collaboration has likely enriched the research and development process in which they have been involved.
Conclusion
Adam Jan Sanderson's innovative work in the modulation of acetylcholine receptors has the potential to significantly impact the treatment of various neurological disorders. His contributions to the field are commendable and reflect his dedication to advancing medical science.